Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for women with unresectable ovarian cancer: a single-center, open phase IB/II clinical trial

被引:0
|
作者
Yin, Lina [1 ]
Jiang, Wei [1 ]
Shan, Boer [1 ]
Yang, Huijuan [1 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Gynecol Oncol, Shanghai, Peoples R China
关键词
D O I
10.1136/ijgc-2023-IGCS.387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP326
引用
收藏
页码:A211 / A212
页数:2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL PLUS CARBOPLATIN AS NEOADJUVANT CHEMOTHERAPY FOR WOMEN WITH UNRESECTABLE OVARIAN CANCER: A SINGLE-CENTER, OPEN PHASE IB/II CLINICAL TRIAL
    Yin, Lina
    Jiang, Wei
    Shan, Boer
    Yang, Huijuan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A178 - A178
  • [2] Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III-IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study
    Yin, Lina
    Jiang, Wei
    Liu, Shuai
    Fu, Yi
    Zhou, Lin
    Pei, Xuan
    Ye, Shuang
    Shen, Wenbin
    Yang, Huijuan
    Shan, Boer
    BMC MEDICINE, 2024, 22 (01):
  • [3] Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
    Huan Wang
    Lingyun Fan
    Xia Wu
    Yimin Han
    BMC Women's Health, 22
  • [4] Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
    Wang, Huan
    Fan, Lingyun
    Wu, Xia
    Han, Yimin
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [5] Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Yasui, Hirofumi
    Goto, Masahiro
    Muro, Kei
    Tsuji, Akihito
    Koizumi, Wasaburo
    Toh, Yasushi
    Hara, Takuo
    Miyata, Yoshinori
    CANCER SCIENCE, 2014, 105 (07) : 812 - 817
  • [6] Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer
    Yang, Miaomiao
    Qu, Huajun
    Liu, Aina
    Liu, Jiannan
    Sun, Ping
    Li, Hua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1561 - 1566
  • [7] Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer
    Xie, Fei
    Chen, Rui
    Zhang, Ling
    Yin, Zinan
    Zhu, Qiannan
    You, Sainan
    Jiang, Chaojun
    Li, Yan
    Li, Shuo
    Zha, Xiaoming
    Wang, Jue
    NANOMEDICINE, 2019, 14 (12) : 1595 - 1603
  • [8] Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer
    Mrozek, Ewa
    Layman, Rachel
    Ramaswamy, Bhuvaneswari
    Lustberg, Maryam
    Vecchione, Andrea
    Knopp, Michael V.
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2014, 14 (04) : 228 - 234
  • [9] Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer
    Motooka, Y.
    Matsuishi, K.
    Maruyama, R.
    Yoshimoto, K.
    Sakata, S.
    Aoki, M.
    Marutsuka, T.
    Tanaka, F.
    Suetsugu, T.
    Suzuki, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S528 - S529
  • [10] Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer ABOUND.sqm): A Phase III Randomized Clinical Trial
    Spigel, David R.
    Jotte, Robert M.
    Aix, Santiago Ponce
    Gressot, Laurent
    Morgensztern, Daniel
    McCleod, Michael
    Socinski, Mark A.
    Daniel, Davey
    Juan-Vidal, Oscar
    Mileham, Kathryn F.
    West, Howard
    Page, Ray
    Reinmuth, Niels
    Knoble, Jeanna
    Chen, Tianlei
    Bhore, Rafia
    Wolfsteiner, Marianne
    Ong, Teng Jin
    Gridelli, Cesare
    Thomas, Michael
    CLINICAL LUNG CANCER, 2021, 22 (01) : 6 - +